Aelis Farma【AELIS】銘柄情報

Aelis Farma SA (AELIS) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

1.05

( -2.23% )

買値

1.05

売値

1.07

出来高

2,563

平均取引量 (3 か月)

24,641 €

財務取引量

1.05 日の範囲 1.07

0.672 52 週間の範囲 2.30

時価総額

14.276M

企業価値

12.037M

前日終値

1.074

始値

1.07

時刻

516

1.05

最終取引時間

VWAP

歳入

2.08M

純利益

-6.43M

発行済株式数

13,596,550

浮動株比率 (%)

28.58%

機関投資家保有比率 (%)

31.05%

配当利回り

PER

-2.21

株価売上高倍率 (PSR)

6.79

1 株当たり利益 (EPS)

-0.47

ベータ

0.61

Aelis Farma SA, a clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France. The company is developing signaling-specific inhibitors of the CB1 receptors, such as AEF0117, a drug candidate, which is... Aelis Farma SA, a clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France. The company is developing signaling-specific inhibitors of the CB1 receptors, such as AEF0117, a drug candidate, which is in Phase 2b clinical trials for the treatment of the harmful effects of excessive cannabis use; and AEF0217, a drug candidate, which is in phase II clinical trials to treat cognitive deficits observed in down syndrome, as well as other cognitive impairments. Aelis Farma SA was incorporated in 2013 and is headquartered in Bordeaux, France. 詳細を表示

セクター

Health Care

業界

ウェブサイト

www.aelisfarma.com

本社

Bordeaux, France

設立

2026

Aelis Farma SA is listed in the Health Care sector of the ユーロネクスト with ticker AELIS. The last closing price for Aelis Farma was 1.07 €. Over the last year, Aelis Farma shares have traded in a share price range of 0.672 € to 2.30 €.

Aelis Farma currently has 13,596,550 shares in issue. The market capitalisation of Aelis Farma is 14.28 € million. Aelis Farma has a price to earnings ratio (PE ratio) of -2.21.

Aelis Farma : Bilan semestriel du contrat de liquidité conclu avec Invest Securities

Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique...

Aelis Farma: Availability of the Description of the Share Buyback Program

Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of...

Results of Aelis Farma Combined General Meeting of May 27, 2025

Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), clinical-stage biopharmaceutical company specializing in the development of...

Aelis Farma : Assemblée générale mixte du 27 mai 2025 : mise à disposition des documents préparatoires et modalités de participation et de vote

Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique...

Aelis Farma : Mise à disposition du Document d’Enregistrement Universel 2024

Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique...

Aelis Farma Reports Its 2024 Annual Financial Results and Confirms Its 2025 Outlook

2024 has been marked by several significant events: The achievement of key milestones for the Company's two drug candidates: AEF0117:...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.02	1.94174757282	1.03	1.1	0.995	9658	1.04873583	DE
4	-0.05	-4.54545454545	1.1	1.19	0.95	17323	1.04111075	DE
12	-0.25	-19.2307692308	1.3	1.34	0.95	23890	1.19416992	DE
26	-0.135	-11.3924050633	1.185	2.3	0.95	46809	1.47613403	DE
52	0.06	6.06060606061	0.99	2.3	0.672	43894	1.32583724	DE
156	-12.9	-92.4731182796	13.95	13.95	0.672	18563	1.47087843	DE
260	-12.45	-92.2222222222	13.5	14.48	0.672	12738	1.71858288	DE